Ali Moussa to Aged, 80 and over
This is a "connection" page, showing publications Ali Moussa has written about Aged, 80 and over.
Connection Strength
0.025
-
Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma. Br J Cancer. 2017 Feb 14; 116(4):432-440.
Score: 0.025